Ann: Change of Director's Interest Notice - M. Washer, page-12

The fact that no one has been able to solve this dilemma makes AusCann's following releases even more exciting I guess

"AusCann has completed a successful pilot study of an optimal final dose form for its proprietary cannabinoid medicines. New dose form solves the problem of stability of medical cannabis products currently on market. The study was carried out over the past ten months to be ready for the release of
AusCann’s first cannabinoid medicines in first half of 2019"

"AusCann has developed a unique effective stable oral dose form which provides consistent and stable dosages of the active cannabinoids with reliable bioavailability. AusCann has lodged a patent in respect to the intellectual property it has developed and will be used in the production of its first stage cannabinoid pharmaceuticals being released in first half of 2019."

"New proprietary solid hard shell capsules for treatment of chronic pain are scheduled for release in H1 2019. Australia’s leading wholesaler of pharmaceutical products, Australian Pharmaceutical Industries Limited (API) will manufacture AusCann’s hard shell capsules at its manufacturing facilities in Australia"

Sounds like a lot of work for a product you claim doesn't work just based on some internet articles you read?